Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13141790 | 0.76 | — | — | |
| SCHEMBL755487 | 0.67 | KMT2A (0.39) | KMT2ATSHRHSD11B1 | |
| SCHEMBL93393 | 0.67 | KMT2A (0.39) | KMT2ARAB9ATSHRHSD11B1 | |
| SCHEMBL4837194 | 0.67 | KMT2A (0.39) | KMT2ARAB9ATSHRHSD11B1 | |
| SCHEMBL7698150 | 0.67 | KMT2A (0.31) | KMT2A | |
| SCHEMBL9019859 | 0.65 | DGAT1 (0.34) | SMN1; SMN2 | |
| SCHEMBL9566006 | 0.65 | KMT2A (0.37) | KMT2ARAB9ATSHRHSD11B1 | |
| SCHEMBL15788938 | 0.65 | KMT2A (0.37) | KMT2ARAB9ATSHRHSD11B1 | |
| SCHEMBL7141290 | 0.65 | KMT2A (0.37) | KMT2ARAB9ATSHRHSD11B1 | |
| SCHEMBL21405194 | 0.65 | KMT2A (0.37) | KMT2ARAB9ATSHRHSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365541-A1 | INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF | XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) | 2023-11-16 | — | — | US | disclosed |
| US-20040215030-A1 | Precursors for metal containing films | VERSUM MATERIALS US, LLC | 2004-10-28 | — | — | US | disclosed |
| EP-1471568-A1 | Precursors for metal containing films | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2004-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365541-A1 | INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF | EZH2, BMI1, EZH1 | KMT2A 17/4885RAB9A 2688/4885SMN1; SMN2 903/4885 |
| US-20040215030-A1 | Precursors for metal containing films | TBL3, TBL2, TNNI3 | KMT2A 802/4885RAB9A 2003/4885SMN1; SMN2 492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.